Background
Surgical exploration of the posterior fossa is the definitive treatment for trigeminal neuralgia refractory to medication, but predictors of its success in effecting long-term pain relief have not been established.
Objective
To develop a model that allows stratification of patients' risk of postoperative recurrence of pain based on pretreatment factors.
Methods
We reviewed the records of 420 consecutive patients who underwent posterior fossa exploration by one of us (C.B.W.) for the treatment of idiopathic trigeminal neuralgia. The primary outcome measure was recurrence of trigeminal pain. The predictive value of preoperative and intraoperative factors was evaluated. Multivariate analysis revealed the statistically significant predictors of pain recurrence, permitting creation of a risk model for recurrence of pain.
Results
After surgery, trigeminal pain had lessened in 98% of patients and completely resolved in 87%. There were no perioperative deaths. After a mean follow-up of 56.3 months, 93% of patients reported significant pain improvement and 72% continued to have no pain. The estimated likelihood of pain recurrence at 8 years was 34%. Significant predictors of eventual recurrence of pain were age younger than 53 years at the time of surgery, symptoms lasting longer than 11½ years, female sex, and pain on the left side in men. These factors were weighted and incorporated into a risk model that revealed 4-year pain-free survival of 89% ± 4% for the low-risk group, 80% ± 4% for the moderate-risk group, and 58% ± 6% for the high-risk group (data are mean ± SD).
Conclusions
We developed a predictive model that stratifies the risk for eventual recurrence of pain after posterior fossa exploration for trigeminal neuralgia. This information may be useful in counseling patients regarding treatment.
TRIGEMINAL NEURALGIA is one of the most common causes of facial pain. It is characterized by transient episodes of lancinating pain in the trigeminal distribution, often precipitated by mild mechanical irritation from activities such as brushing the teeth or chewing. Although the pathogenesis is controversial, there are effective treatments. Once medical treatments fail, surgical intervention may be advocated.1-3 Percutaneous lesions of the trigeminal nerve or ganglion, exploration of the posterior fossa for microvascular decompression (MVD), partial sensory rhizotomy (PSR) at the nerve root entry zone, and, more recently, stereotactic radiosurgery have been shown to ameliorate symptoms.2,4-47
Among the surgical treatments, posterior fossa exploration is often the preferred initial treatment, because it affords the highest success rate with the lowest complication rate.19-21,37 Several studies4,6,23,25,48,49 have assessed factors that predict pain relief after posterior fossa exploration for trigeminal neuralgia. A short duration of symptoms, absence of prior destructive procedures, male sex, and arterial compression of the nerve root entry zone, either individually or in combination, are predictive of long-term pain relief. Still, there is no consensus about predictors among the various studies, and there is no model that incorporates predictors to stratify the risk of postoperative recurrence based on pretreatment patient characteristics.
We performed this retrospective study to determine predictors of pain relief after posterior fossa exploration and to create a model for predicting the risk of pain recurrence.
All patients who consecutively underwent posterior fossa exploration (n = 420) for the treatment of idiopathic trigeminal neuralgia by one of us (C.B.W.) at our institution between June 1969 and September 1998 were eligible for inclusion in the study. Patients who had multiple sclerosis, a posterior fossa lesion (eg, tumor, aneurysm, or vascular malformation), or prior posterior fossa exploration were excluded. Prior percutaneous procedures for the treatment of trigeminal neuralgia were allowed.
All procedures were performed by using techniques described elsewhere.50,51 Based on operative findings, patients were treated by MVD, PSR, or both. Microvascular decompression was performed when nerve root distortion resulted from external vascular compression. Veins were coagulated and divided, whereas arteries were dissected away from the nerve and displaced with a Teflon sponge. In patients without vascular contact, a PSR was performed. A combination of MVD and PSR was performed in patients with vascular contact but without deformity of the nerve root.
After obtaining approval from The University of California, San Francisco, Committee on Human Research, we reviewed the demographic and clinical characteristics of all patients. Information about immediate postoperative and long-term trigeminal pain status was obtained from hospital charts and from letters that patients had been asked to write annually, after discharge from the hospital. When no long-term follow-up information was on file, patients were interviewed by telephone. Information about persistence or recurrence of pain, medication use, timing of relapse, and additional procedures performed was collected.
Two groups of patients were defined for the purpose of data analysis. Group A included all patients (n = 420) whose immediate postoperative trigeminal pain status was known. This group was used for the analysis of immediate postoperative outcome. The subset of group A (n = 292) with immediate postoperative resolution of trigeminal pain and follow-up for 12 months or longer was defined as group B, which was used for the long-term outcome analysis and the development of a predictive model for pain recurrence. To validate the proposed model, we randomly divided group B into 2 subgroups in a two-thirds–one-third ratio. The larger subgroup was used for an analysis that determined the statistically significant factors for pain recurrence within each subgroup, whereas the smaller subgroup was used to validate the results of this analysis. The validation process consisted of 3 independent trials of group B division and analysis.
Predictive factors for immediate postoperative outcome were assessed by logistic regression analysis. The predictive model for long-term outcome was generated using Cox regression analysis and proportional hazard calculation. Factors considered as predictors in all analyses were the patient's sex, age, side and trigeminal distribution of pain, duration of symptoms, prior percutaneous procedures, and presence of vascular compression as determined intraoperatively. Age and duration of symptoms were assessed as dichotomous variables, divided at a significant cutoff point to simplify the analysis. The logistic and Cox regressions included univariate analyses, followed by multivariate analysis, first looking at each pair of factors and their interaction and then including all factors and any significant interactions. A Kaplan-Meier survival plot was created for all patients with a postoperative follow-up of 12 months or longer. Time to recurrence of pain after a successful postoperative outcome was designated as the midpoint between the patient's latest follow-up evaluation without pain and the next evaluation when recurrence of pain was reported. Sensitivity analysis included time to recurrence of pain. Minimum time is defined as the latest follow-up evaluation without pain and maximum time, as the first follow-up evaluation with pain recurrence. The results were similar and are not presented. Statistical significance for all analyses was defined as P = .05 (2-tailed).
During the study, 648 posterior fossa explorations for trigeminal neuralgia were performed in 586 patients. Eight patients had posterior fossa tumors, 12 had multiple sclerosis, and 106 had previously undergone 1 or more posterior fossa explorations. There was insufficient follow-up information for 102 patients. Group A consisted of 420 patients. The age and sex of the patients for whom no follow-up information was available were similar to those of the patients in group A. Group B consisted of 292 patients. Table 1 shows demographic and clinical characteristics for both groups. There were no differences in baseline characteristics between patients with and without long-term follow-up.
There were 225 MVD, 81 PSR, and 114 combination MVD and PSR procedures performed. After surgery, 98% (n = 411) reported lessening of their pain, with 87% (n = 367) experiencing complete pain relief and 13% (n = 53) having some pain persistence.
Univariate and multivariate logistic regression analyses for immediate postoperative resolution of pain revealed pain on the left side (P = .007) and longer than 11½ years' duration of symptoms (P = .04) as significant predictive factors. Involvement of the V3 distribution of the trigeminal nerve was also a significant predictor (P = .04) in univariate analysis but was not significant in multivariate analysis (Table 2).
In group B, 76% (n = 222) of the patients had complete pain relief and 90% (n = 264) had lessening of pain at their latest follow-up evaluation. The mean duration of follow-up was 56.3 months for all patients followed up for longer than 12 months and 65.7 months for the subgroup that had no residual pain at their latest follow-up evaluation. The estimated likelihood of pain recurrence by 8 years was 34% (Figure 1).
Multivariate analysis revealed age younger than 53 years at the time of surgery (P<.001), duration of symptoms longer than 11½ years (P = .04), and female sex and pain on the left side in men (P = .02) as predictors of long-term pain recurrence (Table 3). These factors remained significant in all 3 subgroup iterations (results not shown).
Based on the results of the multivariate analysis of long-term outcome predictors, we developed a model for predicting the risk of eventual recurrence of pain. Three risk groups were identified—high, moderate, and low risk—depending on the risk factors each patient possessed. Based on the hazard ratios, we defined female sex and pain on the left side in men as major risk factors, and symptom duration of 11½ years or longer and age younger than 53 years at the time of surgery as minor risk factors. The low-risk group included patients with only 1 minor risk factor (n = 65). The moderate-risk group included patients with only 1 major risk factor (n = 143). The high-risk group included patients with any combination of 2 or more risk factors (n = 84) (Table 4). A survival curve according to risk group was then created, including all patients followed up for 12 months or longer (Figure 2).
For patients with immediate postoperative pain resolution, pain-free survival at 4 and 10 years, respectively, after surgery was 89% ± 4% at both end points for the low-risk group, 80% ± 4% and 71% ± 5% for the moderate-risk group, and 58% ± 6% and 47% ± 7% for the high-risk group (data are given as mean ± SD). For all patients followed up for 12 months or longer, regardless of initial pain resolution, the mean pain-free survival at 4 and 10 years, respectively, was 87% ± 4% at both end points for the low-risk group, 77% ± 4% and 68% ± 5% for the moderate-risk group, and 56% ± 5% and 47% ± 6% for the high-risk group.
There were no perioperative deaths in this series. Major complications included hearing loss, hydrocephalus requiring a procedure to divert cerebrospinal fluid, anesthesia dolorosa, and intracranial hemorrhage (Table 5).
Posterior fossa exploration lessened trigeminal pain in 98% of patients and provided complete pain relief in 87% immediately after surgery. After a mean follow-up of 56.3 months, 76% of the patients in this series reported complete pain resolution, while 90% reported significant pain improvement. These results compare favorably with the results of studies4,6 of MVD alone in the treatment of idiopathic trigeminal neuralgia, which reveal a 70% pain resolution rate.
The recurrence of trigeminal pain after initial complete resolution is an issue that is often raised in the literature and in clinical practice. For patients who were pain free after surgery, the model of risk for the recurrence of pain described in this report predicts long-term pain status for low-, moderate-, and high-risk groups. Younger age,23 duration of symptoms,4,5,12 and female sex4,5,52 have been reported as predictors of long-term pain recurrence. The combination of male sex and pain on the left side has not been reported as an important predictor of long-term outcome. The cause of this relationship is unclear.
We found no connection between long-term outcome and type of compression at the nerve root entry zone, a factor that previous studies4,6,17,52 have related to outcome. Our study is different from those, however, in that treatment was different for each patient, depending on the presence and type of compression. As others have previously observed,48 trigeminal neuralgia exists without significant compression of the nerve root, and in those cases we believe MVD to be inadequate treatment.
Posterior fossa exploration appears to be a safe treatment for trigeminal neuralgia. The most important morbidities of posterior fossa exploration include hearing loss (usually secondary to retraction injury to the cochlear nerve), development of hydrocephalus and cerebrospinal fluid leakage as a result of perioperative aseptic meningitis, cerebellar hemorrhagic stroke, and death. In a series of 4400 consecutive posterior fossa explorations for MVD of cranial nerves, McLaughlin et al21 reported complication rates as high as 0.9% for cerebellar injury, 2% for hearing loss, and 2.5% for clinically significant CSF leakage. The overall morbidity rates in our series are comparable to those previously published, and, unlike previous reports, this series involved no perioperative mortality. Although one may argue that a patient's advanced age can lead to unacceptable morbidity, we withheld posterior fossa exploration only for absolute anesthetic contraindications. Therefore, our results reinforce the conclusion drawn by Ryu and colleagues30 that posterior fossa exploration can be successful and safe in older patients.
For the past 10 years, stereotactic radiosurgery has become an alternative treatment for trigeminal neuralgia. Several studies report complete pain relief of up to 85% at 1 year53-56 and 56% at 5 years.53 Although maximum radiation dose was variable among the studies (60-90 Gy), patients treated with 70 Gy or higher had a statistically increased chance of complete pain relief.
Trigeminal dysfunction, primarily dysesthesias, is the most common complication of the procedure, with an occurrence rate of 6% to 66%.45,53,54,56 There is an observed significant association between higher radiation dose and the development of trigeminal dysesthesias.56
Stereotactic irradiation appears to be a promising treatment for typical trigeminal neuralgia, but it is not as effective in persistent complete pain relief as posterior fossa exploration. Given the significantly lower morbidity, it may be an appealing treatment in patients with recurrences following surgical exploration or with multiple medical problems and high anesthetic risks.
Our analysis has several limitations. Despite the prospective manner in which some of the follow-up data were obtained, it is a retrospective review. The treatment was not uniform, as 3 types of procedures were used. Although the number of patients represents the second largest published series of patients undergoing posterior fossa exploration for treatment of trigeminal neuralgia, the series is too small to permit a completely independent validation group for the prediction model or to identify risk factors that are less prevalent. The dichotomous presentation of the various predictors in the long-term outcome model does not adequately represent clinical practice. Uniform trends were identified in all the predictors along their range of values, but statistical considerations and the small size of the patient sample size made it necessary to include the most significant cutoff values in the model. We believe the model is illustrative of a continuous risk for pain recurrence, and it should be used with caution when applied to patients with characteristics close to the cutoff values.
Despite these limitations, we believe this analysis and the derived model are accurate. This is a large series of patients who underwent posterior fossa exploration for 29 years. The same surgeon performed all procedures, and the selection criteria for which surgery was performed remained unchanged throughout the series. With regard to the model, the primary analysis was supplemented with internal validation, which in all 3 iterations showed agreement in the model development and validation subgroups.
We report the outcome of posterior fossa exploration for trigeminal neuralgia and a validated model for risk stratification for eventual recurrence of trigeminal pain. We expect the model to be a useful instrument in more accurate decision making about treatment and in better counseling of patients with trigeminal neuralgia.
Accepted for publication March 13, 2002.
We thank Susan Eastwood, ELS(D), for critical review and editing of the manuscript.
Author contributions: Study concept and design (Drs Theodosopoulos, Marco, and Wilson); acquisition of data (Drs Theodosopoulos, Marco, and Wilson and Ms Applebury); analysis and interpretation of data (Drs Theodosopoulos, Marco, and Lamborn); drafting of the manuscript (Drs Theodosopoulos, Marco, Lamborn, and Wilson and Ms Applebury); critical revision of the manuscript for important intellectual content (Drs Theodosopoulos, Marco, and Wilson); statistical expertise (Drs Theodosopoulos and Lamborn); obtained funding (Drs Theodosopoulos and Wilson); administrative, technical, and material support (Drs Theodosopoulos, Marco, and Wilson and Ms Applebury); study supervision (Drs Theodosopoulos and Wilson).
Corresponding author and reprints: Philip V. Theodosopoulos, MD, Department of Neurological Surgery, The University of California, San Francisco, 505 Parnassus St, Room M787, Campus Box 0112, San Francisco, CA 94143-0112 (e-mail: theodop@neurosurg.ucsf.edu).
1.Tenser
RB Trigeminal neuralgia: mechanisms of treatment.
Neurology.1998;51:17-19.
Google Scholar 2.Sweet
WH The treatment of trigeminal neuralgia (tic douloureux).
N Engl J Med.1986;315:174-177.
Google Scholar 3.Kitt
CAGruber
KDavis
MWoolf
CJLevine
JD Trigeminal neuralgia: opportunities for research and treatment.
Pain.2000;85:3-7.
Google Scholar 4.Barker II
FGJannetta
PJBissonette
DJLarkins
MVJho
HD The long-term outcome of microvascular decompression for trigeminal neuralgia.
N Engl J Med.1996;334:1077-1083.
Google Scholar 5.Bederson
JBWilson
CB Evaluation of microvascular decompression and partial sensory rhizotomy in 252 cases of trigeminal neuralgia.
J Neurosurg.1989;71:359-367.
Google Scholar 6.Burchiel
KJClarke
HHaglund
MLoeser
JD Long-term efficacy of microvascular decompression in trigeminal neuralgia.
J Neurosurg.1988;69:35-38.
Google Scholar 7.Broggi
GFranzini
ALasio
GGiorgi
CServello
D Long-term results of percutaneous retrogasserian thermorhizotomy for "essential" trigeminal neuralgia: considerations in 1000 consecutive patients.
Neurosurgery.1990;26:783-787.
Google Scholar 8.Choi
CHFisher III
WS Microvascular decompression as a therapy for trigeminal neuralgia.
Microsurgery.1994;15:527-533.
Google Scholar 9.Correa
CFTeixeira
MJ Balloon compression of the gasserian ganglion for the treatment of trigeminal neuralgia.
Stereotact Funct Neurosurg.1998;71:83-89.
Google Scholar 10.Goya
TWakisaka
SKinoshita
K Microvascular decompression for trigeminal neuralgia with special reference to delayed recurrence.
Neurol Med Chir (Tokyo).1990;30:462-467.
Google Scholar 11.Ischia
SLuzzani
APolati
E Retrogasserian glycerol injection: a retrospective study of 112 patients.
Clin J Pain.1990;6:291-296.
Google Scholar 12.Apfelbaum
RI Surgery for tic douloureux.
Clin Neurosurg.1983;31:351-368.
Google Scholar 13.Ischia
SLuzzani
APolati
EIschia
A Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia.
Clin J Pain.1990;6:96-104.
Google Scholar 14.Jannetta
PJ Microsurgical management of trigeminal neuralgia.
Arch Neurol.1985;42:800.
Google Scholar 15.Jannetta
PJ Outcome after microvascular decompression for typical trigeminal neuralgia, hemifacial spasm, tinnitus, disabling positional vertigo, and glossopharyngeal neuralgia (honored guest lecture).
Clin Neurosurg.1997;44:331-383.
Google Scholar 16.Jho
HDLunsford
LD Percutaneous retrogasserian glycerol rhizotomy: current technique and results.
Neurosurg Clin N Am.1997;8:63-74.
Google Scholar 17.Klun
B Microvascular decompression and partial sensory rhizotomy in the treatment of trigeminal neuralgia: personal experience with 220 patients.
Neurosurgery.1992;30:49-52.
Google Scholar 18.Kondo
A Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm.
Neurosurgery.1997;40:46-52.
Google Scholar 19.Lee
KHChang
JWPark
YGChung
SS Microvascular decompression and percutaneous rhizotomy in trigeminal neuralgia.
Stereotact Funct Neurosurg.1997;68(pt 1):196-199.
Google Scholar 20.Lovely
TJJannetta
PJ Microvascular decompression for trigeminal neuralgia: surgical technique and long-term results.
Neurosurg Clin N Am.1997;8:11-29.
Google Scholar 21.McLaughlin
MRJannetta
PJClyde
BLSubach
BRComey
CHResnick
DK Microvascular decompression of cranial nerves: lessons learned after 4400 operations.
J Neurosurg.1999;90:1-8.
Google Scholar 22.Meglio
MCioni
BMoles
AVisocchi
M Microvascular decompression versus percutaneous procedures for typical trigeminal neuralgia: personal experience.
Stereotact Funct Neurosurg.1990;54-55:76-79.
Google Scholar 23.Mendoza
NIllingworth
RD Trigeminal neuralgia treated by microvascular decompression: a long-term follow-up study.
Br J Neurosurg.1995;9:13-19.
Google Scholar 24.North
RBKidd
DHPiantadosi
SCarson
BS Percutaneous retrogasserian glycerol rhizotomy: predictors of success and failure in treatment of trigeminal neuralgia.
J Neurosurg.1990;72:851-856.
Google Scholar 25.Puca
AMeglio
MCioni
BVisocchi
MVari
R Microvascular decompression for trigeminal neuralgia: prognostic factors.
Acta Neurochir Suppl (Wien).1993;58:165-167.
Google Scholar 26.Rand
RW Leksell gamma knife treatment of tic douloureux.
Neurosurg Clin N Am.1997;8:75-78.
Google Scholar 27.Rath
SAKlein
HJRichter
HP Findings and long-term results of subsequent operations after failed microvascular decompression for trigeminal neuralgia.
Neurosurgery.1996;39:933-940.
Google Scholar 28.Regis
JBartolomei
FMetellus
P
et al Radiosurgery for trigeminal neuralgia and epilepsy.
Neurosurg Clin N Am.1999;10:359-377.
Google Scholar 30.Ryu
HYamamoto
SSugiyama
KYokota
NTanaka
T Neurovascular decompression for trigeminal neuralgia in elderly patients.
Neurol Med Chir (Tokyo).1999;39:226-230.
Google Scholar 31.Scrivani
SJKeith
DAMathews
ESKaban
LB Percutaneous stereotactic differential radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia.
J Oral Maxillofac Surg.1999;57:104-112.
Google Scholar 32.Sindou
MMertens
P Microsurgical vascular decompression (MVD) in trigeminal and glosso-vago-pharyngeal neuralgias: a twenty-year experience.
Acta Neurochir Suppl (Wien).1993;58:168-170.
Google Scholar 33.Spendel
MCDeinsberger
RLanner
G Operative treatment of trigeminal neuralgia.
Stereotact Funct Neurosurg.1997;68(pt 1):187-189.
Google Scholar 34.Sun
TSaito
SNakai
OAndo
T Long-term results of microvascular decompression for trigeminal neuralgia with reference to probability of recurrence.
Acta Neurochir (Wien).1994;126:144-148.
Google Scholar 35.Taarnhøj
P Decompression of the posterior trigeminal root in trigeminal neuralgia: a 30-year follow-up review.
J Neurosurg.1982;57:14-17.
Google Scholar 36.Taha
JMTew Jr
JMBuncher
CR A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy.
J Neurosurg.1995;83:989-993.
Google Scholar 37.Taha
JMTew Jr
JM Comparison of surgical treatments for trigeminal neuralgia: reevaluation of radiofrequency rhizotomy.
Neurosurgery.1996;38:865-871.
Google Scholar 38.Taha
JMTew Jr
JM Treatment of trigeminal neuralgia by percutaneous radiofrequency rhizotomy.
Neurosurg Clin N Am.1997;8:31-39.
Google Scholar 39.Urgosik
DVymazal
JVladyka
VLiscak
R Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study.
Stereotact Funct Neurosurg.1998;70(suppl 1):200-209.
Google Scholar 40.Wilkinson
HA Trigeminal nerve peripheral branch phenol/glycerol injections for tic douloureux.
J Neurosurg.1999;90:828-832.
Google Scholar 41.Yoon
KBWiles
JRMiles
JBNurmikko
TJ Long-term outcome of percutaneous thermocoagulation for trigeminal neuralgia.
Anaesthesia.1999;54:803-808.
Google Scholar 42.Young
RFVermeulen
SPosewitz
A Gamma knife radiosurgery for the treatment of trigeminal neuralgia.
Stereotact Funct Neurosurg.1998;70(suppl 1):192-199.
Google Scholar 43.Zakrzewska
JMJassim
SBulman
JS A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the gasserian ganglion.
Pain.1999;79:51-58.
Google Scholar 44.Kondziolka
DFlickinger
JCLunsford
LDHabeck
M Trigeminal neuralgia radiosurgery: the University of Pittsburgh experience.
Stereotact Funct Neurosurg.1996;66(suppl 1):343-348.
Google Scholar 45.Kondziolka
DLunsford
LDFlickinger
JC
et al Stereotactic radiosurgery for trigeminal neuralgia: a multiinstitutional study using the gamma unit.
J Neurosurg.1996;84:940-945.
Google Scholar 46.Kondziolka
DLunsford
LDHabeck
MFlickinger
JC Gamma knife radiosurgery for trigeminal neuralgia.
Neurosurg Clin N Am.1997;8:79-85.
Google Scholar 47.Kondziolka
DPerez
BFlickinger
JCHabeck
MLunsford
LD Gamma knife radiosurgery for trigeminal neuralgia: results and expectations.
Arch Neurol.1998;55:1524-1529.
Google Scholar 48.Piatt Jr
JHWilkins
RH Treatment of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationships.
Neurosurgery.1984;14:462-471.
Google Scholar 49.Barker II
FGJannetta
PJBissonette
DJJho
HD Trigeminal numbness and tic relief after microvascular decompression for typical trigeminal neuralgia.
Neurosurgery.1997;40:39-45.
Google Scholar 50.Jannetta
PJ Trigeminal neuralgia [letter].
Neurosurgery.1986;18:677.
Google Scholar 51.Zorman
GWilson
CB Outcome following microsurgical vascular decompression or partial sensory rhizotomy in 125 cases of trigeminal neuralgia.
Neurology.1984;34:1362-1365.
Google Scholar 52.Szapiro Jr
JSindou
MSzapiro
J Prognostic factors in microvascular decompression for trigeminal neuralgia.
Neurosurgery.1985;17:920-929.
Google Scholar 53.Maesawa
SSalame
CFlickinger
JCPirris
SKondziolka
DLunsford
LD Clinical outcomes after stereotactic radiosurgery for idiopathic trigeminal neuralgia.
J Neurosurg.2001;94:14-20.
Google Scholar 54.Brisman
R Gamma knife radiosurgery for primary management for trigeminal neuralgia.
J Neurosurg.2000;93(suppl 3):159-161.
Google Scholar 55.Nicol
BRegine
WFCourtney
CMeigooni
ASanders
MYoung
B Gamma knife radiosurgery using 90 Gy for trigeminal neuralgia.
J Neurosurg.2000;93(suppl 3):152-154.
Google Scholar 56.Pollock
BEPhuong
LKFoote
RLStafford
SLGorman
DA High-dose trigeminal neuralgia radiosurgery associated with increased risk of trigeminal nerve dysfunction.
Neurosurgery.2001;49:58-62.
Google Scholar